Medical Care
Global Diverticular Treatment Market Research Report 2025
- Jul 08, 25
- ID: 348837
- Pages: 91
- Figures: 95
- Views: 14
The global market for Diverticular Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Diverticular disease is a digestive condition that leads to the formation of sacs or small bulges in the wall of the large intestine. These sacs can be formed anywhere in the colon, but it is majorly found in the sigmoid colon. Diverticular disease can be caused by many factors such as low fiber diet, lack of physical exercise, and certain medications like anti-inflammatory drugs, lack of vitamin D, obesity, and smoking.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diverticular Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diverticular Treatment.
The Diverticular Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diverticular Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diverticular Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt
Bausch Health Companies Inc
Abbott Laboratories
Novartis AG
Ardelyx
Astellas Pharma Inc
Johnson & Johnson Services
Baxter
Pfizer
Teva Pharmaceutical Industries Ltd
Hikma Pharmaceuticals PLC
Neopharma
Aurobindo pharma
Bayer AG
Viatris
Fresenius Kabi USA
Segment by Type
Medication
Supportive Care
Surgery
Segment by Application
Diverticulosis
Diverticulitis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diverticular Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Diverticular disease is a digestive condition that leads to the formation of sacs or small bulges in the wall of the large intestine. These sacs can be formed anywhere in the colon, but it is majorly found in the sigmoid colon. Diverticular disease can be caused by many factors such as low fiber diet, lack of physical exercise, and certain medications like anti-inflammatory drugs, lack of vitamin D, obesity, and smoking.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diverticular Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diverticular Treatment.
The Diverticular Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diverticular Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diverticular Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt
Bausch Health Companies Inc
Abbott Laboratories
Novartis AG
Ardelyx
Astellas Pharma Inc
Johnson & Johnson Services
Baxter
Pfizer
Teva Pharmaceutical Industries Ltd
Hikma Pharmaceuticals PLC
Neopharma
Aurobindo pharma
Bayer AG
Viatris
Fresenius Kabi USA
Segment by Type
Medication
Supportive Care
Surgery
Segment by Application
Diverticulosis
Diverticulitis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diverticular Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diverticular Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Medication
1.2.3 Supportive Care
1.2.4 Surgery
1.3 Market by Application
1.3.1 Global Diverticular Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diverticulosis
1.3.3 Diverticulitis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diverticular Treatment Market Perspective (2020-2031)
2.2 Global Diverticular Treatment Growth Trends by Region
2.2.1 Global Diverticular Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diverticular Treatment Historic Market Size by Region (2020-2025)
2.2.3 Diverticular Treatment Forecasted Market Size by Region (2026-2031)
2.3 Diverticular Treatment Market Dynamics
2.3.1 Diverticular Treatment Industry Trends
2.3.2 Diverticular Treatment Market Drivers
2.3.3 Diverticular Treatment Market Challenges
2.3.4 Diverticular Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diverticular Treatment Players by Revenue
3.1.1 Global Top Diverticular Treatment Players by Revenue (2020-2025)
3.1.2 Global Diverticular Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Diverticular Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diverticular Treatment Revenue
3.4 Global Diverticular Treatment Market Concentration Ratio
3.4.1 Global Diverticular Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diverticular Treatment Revenue in 2024
3.5 Global Key Players of Diverticular Treatment Head office and Area Served
3.6 Global Key Players of Diverticular Treatment, Product and Application
3.7 Global Key Players of Diverticular Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diverticular Treatment Breakdown Data by Type
4.1 Global Diverticular Treatment Historic Market Size by Type (2020-2025)
4.2 Global Diverticular Treatment Forecasted Market Size by Type (2026-2031)
5 Diverticular Treatment Breakdown Data by Application
5.1 Global Diverticular Treatment Historic Market Size by Application (2020-2025)
5.2 Global Diverticular Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diverticular Treatment Market Size (2020-2031)
6.2 North America Diverticular Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diverticular Treatment Market Size by Country (2020-2025)
6.4 North America Diverticular Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diverticular Treatment Market Size (2020-2031)
7.2 Europe Diverticular Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diverticular Treatment Market Size by Country (2020-2025)
7.4 Europe Diverticular Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diverticular Treatment Market Size (2020-2031)
8.2 Asia-Pacific Diverticular Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diverticular Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Diverticular Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diverticular Treatment Market Size (2020-2031)
9.2 Latin America Diverticular Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diverticular Treatment Market Size by Country (2020-2025)
9.4 Latin America Diverticular Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diverticular Treatment Market Size (2020-2031)
10.2 Middle East & Africa Diverticular Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diverticular Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Diverticular Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mallinckrodt
11.1.1 Mallinckrodt Company Details
11.1.2 Mallinckrodt Business Overview
11.1.3 Mallinckrodt Diverticular Treatment Introduction
11.1.4 Mallinckrodt Revenue in Diverticular Treatment Business (2020-2025)
11.1.5 Mallinckrodt Recent Development
11.2 Bausch Health Companies Inc
11.2.1 Bausch Health Companies Inc Company Details
11.2.2 Bausch Health Companies Inc Business Overview
11.2.3 Bausch Health Companies Inc Diverticular Treatment Introduction
11.2.4 Bausch Health Companies Inc Revenue in Diverticular Treatment Business (2020-2025)
11.2.5 Bausch Health Companies Inc Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Diverticular Treatment Introduction
11.3.4 Abbott Laboratories Revenue in Diverticular Treatment Business (2020-2025)
11.3.5 Abbott Laboratories Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Diverticular Treatment Introduction
11.4.4 Novartis AG Revenue in Diverticular Treatment Business (2020-2025)
11.4.5 Novartis AG Recent Development
11.5 Ardelyx
11.5.1 Ardelyx Company Details
11.5.2 Ardelyx Business Overview
11.5.3 Ardelyx Diverticular Treatment Introduction
11.5.4 Ardelyx Revenue in Diverticular Treatment Business (2020-2025)
11.5.5 Ardelyx Recent Development
11.6 Astellas Pharma Inc
11.6.1 Astellas Pharma Inc Company Details
11.6.2 Astellas Pharma Inc Business Overview
11.6.3 Astellas Pharma Inc Diverticular Treatment Introduction
11.6.4 Astellas Pharma Inc Revenue in Diverticular Treatment Business (2020-2025)
11.6.5 Astellas Pharma Inc Recent Development
11.7 Johnson & Johnson Services
11.7.1 Johnson & Johnson Services Company Details
11.7.2 Johnson & Johnson Services Business Overview
11.7.3 Johnson & Johnson Services Diverticular Treatment Introduction
11.7.4 Johnson & Johnson Services Revenue in Diverticular Treatment Business (2020-2025)
11.7.5 Johnson & Johnson Services Recent Development
11.8 Baxter
11.8.1 Baxter Company Details
11.8.2 Baxter Business Overview
11.8.3 Baxter Diverticular Treatment Introduction
11.8.4 Baxter Revenue in Diverticular Treatment Business (2020-2025)
11.8.5 Baxter Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Diverticular Treatment Introduction
11.9.4 Pfizer Revenue in Diverticular Treatment Business (2020-2025)
11.9.5 Pfizer Recent Development
11.10 Teva Pharmaceutical Industries Ltd
11.10.1 Teva Pharmaceutical Industries Ltd Company Details
11.10.2 Teva Pharmaceutical Industries Ltd Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd Diverticular Treatment Introduction
11.10.4 Teva Pharmaceutical Industries Ltd Revenue in Diverticular Treatment Business (2020-2025)
11.10.5 Teva Pharmaceutical Industries Ltd Recent Development
11.11 Hikma Pharmaceuticals PLC
11.11.1 Hikma Pharmaceuticals PLC Company Details
11.11.2 Hikma Pharmaceuticals PLC Business Overview
11.11.3 Hikma Pharmaceuticals PLC Diverticular Treatment Introduction
11.11.4 Hikma Pharmaceuticals PLC Revenue in Diverticular Treatment Business (2020-2025)
11.11.5 Hikma Pharmaceuticals PLC Recent Development
11.12 Neopharma
11.12.1 Neopharma Company Details
11.12.2 Neopharma Business Overview
11.12.3 Neopharma Diverticular Treatment Introduction
11.12.4 Neopharma Revenue in Diverticular Treatment Business (2020-2025)
11.12.5 Neopharma Recent Development
11.13 Aurobindo pharma
11.13.1 Aurobindo pharma Company Details
11.13.2 Aurobindo pharma Business Overview
11.13.3 Aurobindo pharma Diverticular Treatment Introduction
11.13.4 Aurobindo pharma Revenue in Diverticular Treatment Business (2020-2025)
11.13.5 Aurobindo pharma Recent Development
11.14 Bayer AG
11.14.1 Bayer AG Company Details
11.14.2 Bayer AG Business Overview
11.14.3 Bayer AG Diverticular Treatment Introduction
11.14.4 Bayer AG Revenue in Diverticular Treatment Business (2020-2025)
11.14.5 Bayer AG Recent Development
11.15 Viatris
11.15.1 Viatris Company Details
11.15.2 Viatris Business Overview
11.15.3 Viatris Diverticular Treatment Introduction
11.15.4 Viatris Revenue in Diverticular Treatment Business (2020-2025)
11.15.5 Viatris Recent Development
11.16 Fresenius Kabi USA
11.16.1 Fresenius Kabi USA Company Details
11.16.2 Fresenius Kabi USA Business Overview
11.16.3 Fresenius Kabi USA Diverticular Treatment Introduction
11.16.4 Fresenius Kabi USA Revenue in Diverticular Treatment Business (2020-2025)
11.16.5 Fresenius Kabi USA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diverticular Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Medication
1.2.3 Supportive Care
1.2.4 Surgery
1.3 Market by Application
1.3.1 Global Diverticular Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diverticulosis
1.3.3 Diverticulitis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diverticular Treatment Market Perspective (2020-2031)
2.2 Global Diverticular Treatment Growth Trends by Region
2.2.1 Global Diverticular Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diverticular Treatment Historic Market Size by Region (2020-2025)
2.2.3 Diverticular Treatment Forecasted Market Size by Region (2026-2031)
2.3 Diverticular Treatment Market Dynamics
2.3.1 Diverticular Treatment Industry Trends
2.3.2 Diverticular Treatment Market Drivers
2.3.3 Diverticular Treatment Market Challenges
2.3.4 Diverticular Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diverticular Treatment Players by Revenue
3.1.1 Global Top Diverticular Treatment Players by Revenue (2020-2025)
3.1.2 Global Diverticular Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Diverticular Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diverticular Treatment Revenue
3.4 Global Diverticular Treatment Market Concentration Ratio
3.4.1 Global Diverticular Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diverticular Treatment Revenue in 2024
3.5 Global Key Players of Diverticular Treatment Head office and Area Served
3.6 Global Key Players of Diverticular Treatment, Product and Application
3.7 Global Key Players of Diverticular Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diverticular Treatment Breakdown Data by Type
4.1 Global Diverticular Treatment Historic Market Size by Type (2020-2025)
4.2 Global Diverticular Treatment Forecasted Market Size by Type (2026-2031)
5 Diverticular Treatment Breakdown Data by Application
5.1 Global Diverticular Treatment Historic Market Size by Application (2020-2025)
5.2 Global Diverticular Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diverticular Treatment Market Size (2020-2031)
6.2 North America Diverticular Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diverticular Treatment Market Size by Country (2020-2025)
6.4 North America Diverticular Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diverticular Treatment Market Size (2020-2031)
7.2 Europe Diverticular Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diverticular Treatment Market Size by Country (2020-2025)
7.4 Europe Diverticular Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diverticular Treatment Market Size (2020-2031)
8.2 Asia-Pacific Diverticular Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diverticular Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Diverticular Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diverticular Treatment Market Size (2020-2031)
9.2 Latin America Diverticular Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diverticular Treatment Market Size by Country (2020-2025)
9.4 Latin America Diverticular Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diverticular Treatment Market Size (2020-2031)
10.2 Middle East & Africa Diverticular Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diverticular Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Diverticular Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mallinckrodt
11.1.1 Mallinckrodt Company Details
11.1.2 Mallinckrodt Business Overview
11.1.3 Mallinckrodt Diverticular Treatment Introduction
11.1.4 Mallinckrodt Revenue in Diverticular Treatment Business (2020-2025)
11.1.5 Mallinckrodt Recent Development
11.2 Bausch Health Companies Inc
11.2.1 Bausch Health Companies Inc Company Details
11.2.2 Bausch Health Companies Inc Business Overview
11.2.3 Bausch Health Companies Inc Diverticular Treatment Introduction
11.2.4 Bausch Health Companies Inc Revenue in Diverticular Treatment Business (2020-2025)
11.2.5 Bausch Health Companies Inc Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Diverticular Treatment Introduction
11.3.4 Abbott Laboratories Revenue in Diverticular Treatment Business (2020-2025)
11.3.5 Abbott Laboratories Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Diverticular Treatment Introduction
11.4.4 Novartis AG Revenue in Diverticular Treatment Business (2020-2025)
11.4.5 Novartis AG Recent Development
11.5 Ardelyx
11.5.1 Ardelyx Company Details
11.5.2 Ardelyx Business Overview
11.5.3 Ardelyx Diverticular Treatment Introduction
11.5.4 Ardelyx Revenue in Diverticular Treatment Business (2020-2025)
11.5.5 Ardelyx Recent Development
11.6 Astellas Pharma Inc
11.6.1 Astellas Pharma Inc Company Details
11.6.2 Astellas Pharma Inc Business Overview
11.6.3 Astellas Pharma Inc Diverticular Treatment Introduction
11.6.4 Astellas Pharma Inc Revenue in Diverticular Treatment Business (2020-2025)
11.6.5 Astellas Pharma Inc Recent Development
11.7 Johnson & Johnson Services
11.7.1 Johnson & Johnson Services Company Details
11.7.2 Johnson & Johnson Services Business Overview
11.7.3 Johnson & Johnson Services Diverticular Treatment Introduction
11.7.4 Johnson & Johnson Services Revenue in Diverticular Treatment Business (2020-2025)
11.7.5 Johnson & Johnson Services Recent Development
11.8 Baxter
11.8.1 Baxter Company Details
11.8.2 Baxter Business Overview
11.8.3 Baxter Diverticular Treatment Introduction
11.8.4 Baxter Revenue in Diverticular Treatment Business (2020-2025)
11.8.5 Baxter Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Diverticular Treatment Introduction
11.9.4 Pfizer Revenue in Diverticular Treatment Business (2020-2025)
11.9.5 Pfizer Recent Development
11.10 Teva Pharmaceutical Industries Ltd
11.10.1 Teva Pharmaceutical Industries Ltd Company Details
11.10.2 Teva Pharmaceutical Industries Ltd Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd Diverticular Treatment Introduction
11.10.4 Teva Pharmaceutical Industries Ltd Revenue in Diverticular Treatment Business (2020-2025)
11.10.5 Teva Pharmaceutical Industries Ltd Recent Development
11.11 Hikma Pharmaceuticals PLC
11.11.1 Hikma Pharmaceuticals PLC Company Details
11.11.2 Hikma Pharmaceuticals PLC Business Overview
11.11.3 Hikma Pharmaceuticals PLC Diverticular Treatment Introduction
11.11.4 Hikma Pharmaceuticals PLC Revenue in Diverticular Treatment Business (2020-2025)
11.11.5 Hikma Pharmaceuticals PLC Recent Development
11.12 Neopharma
11.12.1 Neopharma Company Details
11.12.2 Neopharma Business Overview
11.12.3 Neopharma Diverticular Treatment Introduction
11.12.4 Neopharma Revenue in Diverticular Treatment Business (2020-2025)
11.12.5 Neopharma Recent Development
11.13 Aurobindo pharma
11.13.1 Aurobindo pharma Company Details
11.13.2 Aurobindo pharma Business Overview
11.13.3 Aurobindo pharma Diverticular Treatment Introduction
11.13.4 Aurobindo pharma Revenue in Diverticular Treatment Business (2020-2025)
11.13.5 Aurobindo pharma Recent Development
11.14 Bayer AG
11.14.1 Bayer AG Company Details
11.14.2 Bayer AG Business Overview
11.14.3 Bayer AG Diverticular Treatment Introduction
11.14.4 Bayer AG Revenue in Diverticular Treatment Business (2020-2025)
11.14.5 Bayer AG Recent Development
11.15 Viatris
11.15.1 Viatris Company Details
11.15.2 Viatris Business Overview
11.15.3 Viatris Diverticular Treatment Introduction
11.15.4 Viatris Revenue in Diverticular Treatment Business (2020-2025)
11.15.5 Viatris Recent Development
11.16 Fresenius Kabi USA
11.16.1 Fresenius Kabi USA Company Details
11.16.2 Fresenius Kabi USA Business Overview
11.16.3 Fresenius Kabi USA Diverticular Treatment Introduction
11.16.4 Fresenius Kabi USA Revenue in Diverticular Treatment Business (2020-2025)
11.16.5 Fresenius Kabi USA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Diverticular Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Medication
Table 3. Key Players of Supportive Care
Table 4. Key Players of Surgery
Table 5. Global Diverticular Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Diverticular Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Diverticular Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Diverticular Treatment Market Share by Region (2020-2025)
Table 9. Global Diverticular Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Diverticular Treatment Market Share by Region (2026-2031)
Table 11. Diverticular Treatment Market Trends
Table 12. Diverticular Treatment Market Drivers
Table 13. Diverticular Treatment Market Challenges
Table 14. Diverticular Treatment Market Restraints
Table 15. Global Diverticular Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Diverticular Treatment Market Share by Players (2020-2025)
Table 17. Global Top Diverticular Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diverticular Treatment as of 2024)
Table 18. Ranking of Global Top Diverticular Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Diverticular Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Diverticular Treatment, Headquarters and Area Served
Table 21. Global Key Players of Diverticular Treatment, Product and Application
Table 22. Global Key Players of Diverticular Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diverticular Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Diverticular Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Diverticular Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Diverticular Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Diverticular Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Diverticular Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Diverticular Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Diverticular Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Diverticular Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Diverticular Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Diverticular Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Diverticular Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Diverticular Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Diverticular Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Diverticular Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Diverticular Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Diverticular Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Diverticular Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Diverticular Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Diverticular Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Diverticular Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Diverticular Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Diverticular Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Mallinckrodt Company Details
Table 48. Mallinckrodt Business Overview
Table 49. Mallinckrodt Diverticular Treatment Product
Table 50. Mallinckrodt Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 51. Mallinckrodt Recent Development
Table 52. Bausch Health Companies Inc Company Details
Table 53. Bausch Health Companies Inc Business Overview
Table 54. Bausch Health Companies Inc Diverticular Treatment Product
Table 55. Bausch Health Companies Inc Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 56. Bausch Health Companies Inc Recent Development
Table 57. Abbott Laboratories Company Details
Table 58. Abbott Laboratories Business Overview
Table 59. Abbott Laboratories Diverticular Treatment Product
Table 60. Abbott Laboratories Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 61. Abbott Laboratories Recent Development
Table 62. Novartis AG Company Details
Table 63. Novartis AG Business Overview
Table 64. Novartis AG Diverticular Treatment Product
Table 65. Novartis AG Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 66. Novartis AG Recent Development
Table 67. Ardelyx Company Details
Table 68. Ardelyx Business Overview
Table 69. Ardelyx Diverticular Treatment Product
Table 70. Ardelyx Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 71. Ardelyx Recent Development
Table 72. Astellas Pharma Inc Company Details
Table 73. Astellas Pharma Inc Business Overview
Table 74. Astellas Pharma Inc Diverticular Treatment Product
Table 75. Astellas Pharma Inc Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 76. Astellas Pharma Inc Recent Development
Table 77. Johnson & Johnson Services Company Details
Table 78. Johnson & Johnson Services Business Overview
Table 79. Johnson & Johnson Services Diverticular Treatment Product
Table 80. Johnson & Johnson Services Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 81. Johnson & Johnson Services Recent Development
Table 82. Baxter Company Details
Table 83. Baxter Business Overview
Table 84. Baxter Diverticular Treatment Product
Table 85. Baxter Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 86. Baxter Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Diverticular Treatment Product
Table 90. Pfizer Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Teva Pharmaceutical Industries Ltd Company Details
Table 93. Teva Pharmaceutical Industries Ltd Business Overview
Table 94. Teva Pharmaceutical Industries Ltd Diverticular Treatment Product
Table 95. Teva Pharmaceutical Industries Ltd Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 96. Teva Pharmaceutical Industries Ltd Recent Development
Table 97. Hikma Pharmaceuticals PLC Company Details
Table 98. Hikma Pharmaceuticals PLC Business Overview
Table 99. Hikma Pharmaceuticals PLC Diverticular Treatment Product
Table 100. Hikma Pharmaceuticals PLC Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 101. Hikma Pharmaceuticals PLC Recent Development
Table 102. Neopharma Company Details
Table 103. Neopharma Business Overview
Table 104. Neopharma Diverticular Treatment Product
Table 105. Neopharma Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 106. Neopharma Recent Development
Table 107. Aurobindo pharma Company Details
Table 108. Aurobindo pharma Business Overview
Table 109. Aurobindo pharma Diverticular Treatment Product
Table 110. Aurobindo pharma Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 111. Aurobindo pharma Recent Development
Table 112. Bayer AG Company Details
Table 113. Bayer AG Business Overview
Table 114. Bayer AG Diverticular Treatment Product
Table 115. Bayer AG Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 116. Bayer AG Recent Development
Table 117. Viatris Company Details
Table 118. Viatris Business Overview
Table 119. Viatris Diverticular Treatment Product
Table 120. Viatris Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 121. Viatris Recent Development
Table 122. Fresenius Kabi USA Company Details
Table 123. Fresenius Kabi USA Business Overview
Table 124. Fresenius Kabi USA Diverticular Treatment Product
Table 125. Fresenius Kabi USA Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 126. Fresenius Kabi USA Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
Table 130. Authors List of This Report
List of Figures
Figure 1. Diverticular Treatment Picture
Figure 2. Global Diverticular Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Diverticular Treatment Market Share by Type: 2024 VS 2031
Figure 4. Medication Features
Figure 5. Supportive Care Features
Figure 6. Surgery Features
Figure 7. Global Diverticular Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Diverticular Treatment Market Share by Application: 2024 VS 2031
Figure 9. Diverticulosis Case Studies
Figure 10. Diverticulitis Case Studies
Figure 11. Diverticular Treatment Report Years Considered
Figure 12. Global Diverticular Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Diverticular Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Diverticular Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Diverticular Treatment Market Share by Players in 2024
Figure 16. Global Top Diverticular Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diverticular Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Diverticular Treatment Revenue in 2024
Figure 18. North America Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Diverticular Treatment Market Share by Country (2020-2031)
Figure 20. United States Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Diverticular Treatment Market Share by Country (2020-2031)
Figure 24. Germany Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Diverticular Treatment Market Share by Region (2020-2031)
Figure 32. China Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Diverticular Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Diverticular Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Mallinckrodt Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 48. Bausch Health Companies Inc Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 49. Abbott Laboratories Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 50. Novartis AG Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 51. Ardelyx Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 52. Astellas Pharma Inc Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 53. Johnson & Johnson Services Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 54. Baxter Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 55. Pfizer Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 56. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 57. Hikma Pharmaceuticals PLC Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 58. Neopharma Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 59. Aurobindo pharma Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 60. Bayer AG Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 61. Viatris Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 62. Fresenius Kabi USA Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Diverticular Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Medication
Table 3. Key Players of Supportive Care
Table 4. Key Players of Surgery
Table 5. Global Diverticular Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Diverticular Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Diverticular Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Diverticular Treatment Market Share by Region (2020-2025)
Table 9. Global Diverticular Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Diverticular Treatment Market Share by Region (2026-2031)
Table 11. Diverticular Treatment Market Trends
Table 12. Diverticular Treatment Market Drivers
Table 13. Diverticular Treatment Market Challenges
Table 14. Diverticular Treatment Market Restraints
Table 15. Global Diverticular Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Diverticular Treatment Market Share by Players (2020-2025)
Table 17. Global Top Diverticular Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diverticular Treatment as of 2024)
Table 18. Ranking of Global Top Diverticular Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Diverticular Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Diverticular Treatment, Headquarters and Area Served
Table 21. Global Key Players of Diverticular Treatment, Product and Application
Table 22. Global Key Players of Diverticular Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diverticular Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Diverticular Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Diverticular Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Diverticular Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Diverticular Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Diverticular Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Diverticular Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Diverticular Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Diverticular Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Diverticular Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Diverticular Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Diverticular Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Diverticular Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Diverticular Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Diverticular Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Diverticular Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Diverticular Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Diverticular Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Diverticular Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Diverticular Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Diverticular Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Diverticular Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Diverticular Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Mallinckrodt Company Details
Table 48. Mallinckrodt Business Overview
Table 49. Mallinckrodt Diverticular Treatment Product
Table 50. Mallinckrodt Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 51. Mallinckrodt Recent Development
Table 52. Bausch Health Companies Inc Company Details
Table 53. Bausch Health Companies Inc Business Overview
Table 54. Bausch Health Companies Inc Diverticular Treatment Product
Table 55. Bausch Health Companies Inc Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 56. Bausch Health Companies Inc Recent Development
Table 57. Abbott Laboratories Company Details
Table 58. Abbott Laboratories Business Overview
Table 59. Abbott Laboratories Diverticular Treatment Product
Table 60. Abbott Laboratories Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 61. Abbott Laboratories Recent Development
Table 62. Novartis AG Company Details
Table 63. Novartis AG Business Overview
Table 64. Novartis AG Diverticular Treatment Product
Table 65. Novartis AG Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 66. Novartis AG Recent Development
Table 67. Ardelyx Company Details
Table 68. Ardelyx Business Overview
Table 69. Ardelyx Diverticular Treatment Product
Table 70. Ardelyx Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 71. Ardelyx Recent Development
Table 72. Astellas Pharma Inc Company Details
Table 73. Astellas Pharma Inc Business Overview
Table 74. Astellas Pharma Inc Diverticular Treatment Product
Table 75. Astellas Pharma Inc Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 76. Astellas Pharma Inc Recent Development
Table 77. Johnson & Johnson Services Company Details
Table 78. Johnson & Johnson Services Business Overview
Table 79. Johnson & Johnson Services Diverticular Treatment Product
Table 80. Johnson & Johnson Services Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 81. Johnson & Johnson Services Recent Development
Table 82. Baxter Company Details
Table 83. Baxter Business Overview
Table 84. Baxter Diverticular Treatment Product
Table 85. Baxter Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 86. Baxter Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Diverticular Treatment Product
Table 90. Pfizer Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Teva Pharmaceutical Industries Ltd Company Details
Table 93. Teva Pharmaceutical Industries Ltd Business Overview
Table 94. Teva Pharmaceutical Industries Ltd Diverticular Treatment Product
Table 95. Teva Pharmaceutical Industries Ltd Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 96. Teva Pharmaceutical Industries Ltd Recent Development
Table 97. Hikma Pharmaceuticals PLC Company Details
Table 98. Hikma Pharmaceuticals PLC Business Overview
Table 99. Hikma Pharmaceuticals PLC Diverticular Treatment Product
Table 100. Hikma Pharmaceuticals PLC Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 101. Hikma Pharmaceuticals PLC Recent Development
Table 102. Neopharma Company Details
Table 103. Neopharma Business Overview
Table 104. Neopharma Diverticular Treatment Product
Table 105. Neopharma Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 106. Neopharma Recent Development
Table 107. Aurobindo pharma Company Details
Table 108. Aurobindo pharma Business Overview
Table 109. Aurobindo pharma Diverticular Treatment Product
Table 110. Aurobindo pharma Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 111. Aurobindo pharma Recent Development
Table 112. Bayer AG Company Details
Table 113. Bayer AG Business Overview
Table 114. Bayer AG Diverticular Treatment Product
Table 115. Bayer AG Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 116. Bayer AG Recent Development
Table 117. Viatris Company Details
Table 118. Viatris Business Overview
Table 119. Viatris Diverticular Treatment Product
Table 120. Viatris Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 121. Viatris Recent Development
Table 122. Fresenius Kabi USA Company Details
Table 123. Fresenius Kabi USA Business Overview
Table 124. Fresenius Kabi USA Diverticular Treatment Product
Table 125. Fresenius Kabi USA Revenue in Diverticular Treatment Business (2020-2025) & (US$ Million)
Table 126. Fresenius Kabi USA Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
Table 130. Authors List of This Report
List of Figures
Figure 1. Diverticular Treatment Picture
Figure 2. Global Diverticular Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Diverticular Treatment Market Share by Type: 2024 VS 2031
Figure 4. Medication Features
Figure 5. Supportive Care Features
Figure 6. Surgery Features
Figure 7. Global Diverticular Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Diverticular Treatment Market Share by Application: 2024 VS 2031
Figure 9. Diverticulosis Case Studies
Figure 10. Diverticulitis Case Studies
Figure 11. Diverticular Treatment Report Years Considered
Figure 12. Global Diverticular Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Diverticular Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Diverticular Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Diverticular Treatment Market Share by Players in 2024
Figure 16. Global Top Diverticular Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diverticular Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Diverticular Treatment Revenue in 2024
Figure 18. North America Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Diverticular Treatment Market Share by Country (2020-2031)
Figure 20. United States Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Diverticular Treatment Market Share by Country (2020-2031)
Figure 24. Germany Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Diverticular Treatment Market Share by Region (2020-2031)
Figure 32. China Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Diverticular Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Diverticular Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Diverticular Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Mallinckrodt Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 48. Bausch Health Companies Inc Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 49. Abbott Laboratories Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 50. Novartis AG Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 51. Ardelyx Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 52. Astellas Pharma Inc Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 53. Johnson & Johnson Services Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 54. Baxter Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 55. Pfizer Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 56. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 57. Hikma Pharmaceuticals PLC Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 58. Neopharma Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 59. Aurobindo pharma Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 60. Bayer AG Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 61. Viatris Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 62. Fresenius Kabi USA Revenue Growth Rate in Diverticular Treatment Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232